Increasing knowledge about the benefits of praziquantel |
Include education about praziquantel and schistosomiasis in drug distributor training |
Prepare staff to address common questions, e.g. “Why should I take praziquantel when I don’t have symptoms?” |
Use mass media campaigns (radio, TV, traveling road shows, posters, booklets, brochures) for education |
Conduct education sessions in village meetings, places of worship, markets, and other places where people gather |
Incorporate schistosomiasis/praziquantel education into school curricula |
Reducing fear of side effects |
Provide snacks with MDA distribution |
Schedule MDA when food is more plentiful (e.g. after a harvest) |
Educate community members about the range and transient nature of potential side effects |
Explain the link between worm burden and intensity of side effects and why side effects may thus be worse during the first round of treatment |
Have drug distributors and prominent community members publicly take praziquantel to demonstrate its safety |
Motivating and retaining drug distributors |
Increase distributor-to-recipient ratio to reduce workload |
Provide small financial or material incentives |
Avoid scheduling schistosomiasis MDA concurrently with other health programs that provide incentives |
Avoid scheduling MDA during periods of the year with especially high agricultural or other demands |
Achieving equal coverage in minority groups |
Involve all groups in the community in MDA scheduling and in distributor selection |
Monitor drug distribution in process to guard against inequities in coverage |